Literature DB >> 6528909

How consistent are dermatopathologists in reading early malignant melanomas and lesions "precursor" to them? An international survey.

C Schmoeckel.   

Abstract

Nine cases thought to be "precursors" of malignant melanoma were submitted to 15 histopathologists who have a special interest in melanocytic lesions. The survey revealed that reliable, objective, and repeatable differentiation among benign melanocytic hyperplasias, "precursors," low-risk malignant melanomas, and Spitz's nevi was not achieved. Furthermore, the terminology varied considerably, and some of the same terms were not always used to mean the same things. Clinicians should be aware of the limitations of histopathological interpretations of lesions containing atypical melanocytes. A higher degree of unanimity appears possible when a more simplified and more widely accepted terminology is employed and when differentiating criteria are more clearly established.

Entities:  

Mesh:

Year:  1984        PMID: 6528909

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  4 in total

1.  A nationwide survey of observer variation in the diagnosis of thin cutaneous malignant melanoma including the MIN terminology. CRC Melanoma Pathology Panel.

Authors: 
Journal:  J Clin Pathol       Date:  1997-03       Impact factor: 3.411

2.  Accuracy in clinically evaluating pigmented lesions.

Authors:  R K Curley; M G Cook; M E Fallowfield; R A Marsden
Journal:  BMJ       Date:  1989-07-01

3.  Incidence of childhood and adolescent melanoma in the United States: 1973-2009.

Authors:  Jeannette R Wong; Jenine K Harris; Carlos Rodriguez-Galindo; Kimberly J Johnson
Journal:  Pediatrics       Date:  2013-04-15       Impact factor: 7.124

4.  Morphometric and ultrastructural analyses of melanocytes, nevus cells, and melanoma cells.

Authors:  W Stolz; C Schmoeckel; F Ryckmanns; J Gross; O Braun-Falco
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.